New Vizient Survey Finds Drug Shortages Cost Hospitals Nearly $900M Annually in Labor Expenses
IRVING, Texas--(BUSINESS WIRE)--Vizient® today announced its updated analysis of the financial impact…
Walker & Dunlop Arranges $125 Million Construction Loan for Mixed-Use Property, Cassi in the Miami Design District
BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop, Inc. announced today that it arranged a…
Omdia: LED Video Display Market Grows Steadily in 1Q25, Driven by Micro-LED Adoption and Fine Pixel Pitch Demand
LONDON--(BUSINESS WIRE)--#LED--Global LED video display shipments reached 408,000 square meters and generated…
Lumen Technologies, Inc. Announces Offering of First Lien Notes Due 2033
DENVER--(BUSINESS WIRE)--Lumen Technologies, Inc. (“Lumen”, “us,” “we” or “our”) (NYSE: LUMN) today…
Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#Biotech--Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle…
Lazard Releases 2025 Levelized Cost of Energy+ Report
Renewables Remain Competitive, as Utility-Scale Solar and Onshore Wind Remain Most Cost-Effective…
JD Lands on Las Vegas Strip in Key Moment for US Growth Strategy
JD made waves with the opening of its flagship store on Las…
FANTASTICS from EXILE TRIBE, Former Taipei City Tourism Ambassadors, to Present BACK TO THE MEMORIES PART5 via Livestream!
Presenting a special experience to fans around the world.TOKYO--(BUSINESS WIRE)--ZAIKO will begin…
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
QIAGEN to create a multimodal panel using next-generation sequencing (NGS) technology for…
Positive Late-Breaking Data for Incytes First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025
Data demonstrates the potential for INCA033989 to modify disease by directly inhibiting…